美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ETHZilla Corporation

2.81

-0.0600-2.09%

盤後：2.840.0301+1.07%19:59 EDT

成交量：1,133.98萬

成交額：3,119.43萬

市值：4.65億

市盈率：-0.18

高：2.90

開：2.87

低：2.65

收：2.87

52周最高：17.75

52周最低：0.6578

股本：1.65億

流通股本：1.51億

量比：0.38

換手率：7.51%

股息：- -

股息率：- -

每股收益(TTM):-15.4906

每股收益(LYR):-15.4906

淨資產收益率：-371.02%

總資產收益率：-55.46%

市淨率：86.42

市盈率(LYR):-0.18

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

ETHZilla Corporation

交易所：

NASDAQ

成立時間：

- -

員工人數：

4

公司地址：

2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States

官網：

http://www.180lifesciences.com

郵編：

33480

電話：

傳真：

- -

簡介：

ETHZilla Corporation是一家根據特拉華州法律於2016年9月7日成立的公司。該公司是臨床階段的生物技術公司，致力於開發滿足炎症性疾病，纖維化和疼痛方面未滿足需求的新型藥物。

董事

名稱

職位

Blair Jordan

Chief Executive Officer and Director

McAndrew Rudisill

Executive Chairman

Ryan L. Smith

Lead Independent Director

Stephen H. Shoemaker

Independent Director

Andrew Suckling

Director

Crystal Heter

Director

Jason New

Director

股東

名稱

職位

Blair Jordan

Chief Executive Officer and Director

Eric R. Van Lent

Chief Accounting Officer and Principal Financial Officer

McAndrew Rudisill

Executive Chairman

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ETHZ/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ETHZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETHZ\",,,,,undefined,":{"symbol":"ETHZ","market":"US","secType":"STK","nameCN":"ETHZilla Corporation","latestPrice":2.81,"timestamp":1756497600000,"preClose":2.87,"halted":0,"volume":11339780,"hourTrading":{"tag":"盘后","latestPrice":2.8401,"preClose":2.81,"latestTime":"19:59 EDT","volume":379550,"amount":1069081.6826,"timestamp":1756511977029},"delay":0,"floatShares":151000000,"shares":165478655,"eps":-15.490594,"marketStatus":"休市中","change":-0.06,"latestTime":"08-29 16:00:00 EDT","open":2.87,"high":2.9,"low":2.65,"amount":31194328.64728,"amplitude":0.087108,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.490594,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.87,"preHourTrading":{"tag":"盘前","latestPrice":2.8999,"preClose":2.87,"latestTime":"09:29 EDT","volume":318490,"amount":916549.8850199999,"timestamp":1756474181997},"postHourTrading":{"tag":"盘后","latestPrice":2.8401,"preClose":2.81,"latestTime":"19:59 EDT","volume":379550,"amount":1069081.6826,"timestamp":1756511977029},"volumeRatio":0.38478184214024,"impliedVol":0.9872,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETHZ\",,,,,undefined,":{"symbol":"ETHZ","floatShares":151000000,"roa":"-55.46%","roe":"-371.02%","lyrEps":-15.490594,"volumeRatio":0.38478184214024,"shares":165478655,"dividePrice":0,"high":2.9,"amplitude":0.087108,"preClose":2.87,"low":2.65,"week52Low":0.6578,"pbRate":"86.42","week52High":17.75,"institutionHeld":0,"latestPrice":2.81,"eps":-15.490594,"divideRate":0,"volume":11339780,"delay":0,"ttmEps":-15.490594,"open":2.87,"prevYearClose":1.82,"prevWeekClose":3.3,"prevMonthClose":3.28,"prevQuarterClose":0.9282,"fiveDayClose":3.3,"twentyDayClose":3.54,"sixtyDayClose":1.0692},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ETHZ\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ETHZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ETHZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ETHZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ETHZ","date":"2025-08-29","current":-51.588221,"percent":1,"low":-123.981267,"twenty":-99.620035,"median":-58.947783,"eighty":-55.251403,"high":-51.588221,"avg":-76.340864,"sd":26.546732,"marketCap":474923739},"quantilePoints":[{"date":"2025-08-22","current":-80.479068,"twenty":-120.266848,"median":-102.648458,"eighty":-84.695435,"marketCap":740894324},{"date":"2025-08-29","current":-51.588221,"twenty":-99.620035,"median":-58.947783,"eighty":-55.251403,"marketCap":474923739}],"updateTime":1756583366425},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":587644367,"employeeNum":4,"address":"2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States","zipCode":"33480","officePhone":"650 507 0669"},"stockCompanyDetail":{"websiteUrl":"http://www.180lifesciences.com","stockEarnings":[{"period":"1week","weight":-0.1485},{"period":"1month","weight":-0.2006},{"period":"3month","weight":1.7415},{"period":"6month","weight":1.4017},{"period":"1year","weight":0.5355},{"period":"ytd","weight":0.544}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"ETHZilla Corporation是一家根據特拉華州法律於2016年9月7日成立的公司。該公司是臨床階段的生物技術公司，致力於開發滿足炎症性疾病，纖維化和疼痛方面未滿足需求的新型藥物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.032089},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000209},{"month":3,"riseRate":0.25,"avgChangeRate":-0.079985},{"month":4,"riseRate":0.375,"avgChangeRate":-0.020557},{"month":5,"riseRate":0.5,"avgChangeRate":-0.054077},{"month":6,"riseRate":0.75,"avgChangeRate":-0.042052},{"month":7,"riseRate":0.666667,"avgChangeRate":0.295972},{"month":8,"riseRate":0,"avgChangeRate":-0.113877},{"month":9,"riseRate":0.5,"avgChangeRate":-0.055536},{"month":10,"riseRate":0.25,"avgChangeRate":0.086691},{"month":11,"riseRate":0.25,"avgChangeRate":-0.175583},{"month":12,"riseRate":0.375,"avgChangeRate":-0.169849}],"exchange":"NASDAQ","name":"ETHZilla Corporation","nameEN":"ETHZilla Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ETHZ\",market:\"US\",,,undefined,":{"directors":[{"name":"Blair Jordan","position":"Chief Executive Officer and Director"},{"name":"McAndrew Rudisill","position":"Executive Chairman"},{"name":"Ryan L. Smith","position":"Lead Independent Director"},{"name":"Stephen H. Shoemaker","position":"Independent Director"},{"name":"Andrew Suckling","position":"Director"},{"name":"Crystal Heter","position":"Director"},{"name":"Jason New","position":"Director"}],"executives":[{"name":"Blair Jordan","position":"Chief Executive Officer and Director"},{"name":"Eric R. Van Lent","position":"Chief Accounting Officer and Principal Financial Officer"},{"name":"McAndrew Rudisill","position":"Executive Chairman"}]}}}